Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
0 hedge funds and large institutions have $0 invested in Bionano Genomics, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $91 → $0 (-$91)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$86 |
| 2 |
Morgan Stanley
New York
|
-$5 |
BNGOW Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q3 2023, worth a combined $0 — down 100% from $91 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BNGOW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $86 sold.
- 0 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $0 of Bionano Genomics, Inc. Warrant stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest Bionano Genomics, Inc. Warrant seller in Q3 2023 was LMR Partners, an estimated $86 sold.
Based on aggregated 13F filings for Q3 2023.